{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:29:42Z","timestamp":1778221782234,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX000893"],"award-info":[{"award-number":["BX000893"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.kint.2024.01.014","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T14:20:31Z","timestamp":1710944431000},"page":"661-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interleukin-37: a new therapeutic target in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0680-1469","authenticated-orcid":false,"given":"Bo","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.01.014_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.01.014_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease progression","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.01.014_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.kint.2024.01.014_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152382","article-title":"IL-37 alleviates TNF-\u03b1-induced pyroptosis of rheumatoid arthritis fibroblast-like synoviocytes by inhibiting the NF-\u03baB\/GSDMD signaling pathway","volume":"228","author":"Ren","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.kint.2024.01.014_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109647","article-title":"Role of chemokines, innate and adaptive immunity","volume":"73","author":"Zimmerman","year":"2020","journal-title":"Cell Signal"},{"key":"10.1016\/j.kint.2024.01.014_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.kint.2023.12.006","article-title":"Modulating inflammation with interleukin 37 treatment ameliorates murine Autosomal Dominant Polycystic Kidney Disease","volume":"105","author":"Zylberberg","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.01.014_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2014.295","article-title":"IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury","volume":"87","author":"Yang","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.01.014_bib8","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1073\/pnas.1324140111","article-title":"Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses","volume":"111","author":"Bulau","year":"2014","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382400070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525382400070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:06:25Z","timestamp":1758762385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525382400070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S008525382400070X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.014","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-37: a new therapeutic target in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.12.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}